Ron Fugate

Mr. Fugate is an accomplished 30-year consumer products veteran CEO with deep expertise in the Vitamins, Minerals, and Supplements segment, including time spent running Perricone MD, Renew Life, Yo-Crunch, and Alacer.

Most recently, Mr. Fugate served as CEO of Perricone MD, where he led the transformation of this doctor-founded beauty, skincare, and wellness business in preparation for a sale.

Prior to joining Perricone MD, Mr. Fugate served as CEO/President of three privately-owned middle market CPG companies and led them through sales to strategic acquirers. In 2014, Mr. Fugate served as the CEO of Renew Life, a leader in natural digestive care products, where he led guided the Company in a $290M sale to Clorox. Prior to that, he served as President of Yo-Crunch, where he launched several new products, expanded retail distribution, and drove the sale to Danone, the world’s largest yogurt company. Before Yo-Crunch, Mr. Fugate served as CEO and President of Alacer, where he helped establish Emergen-C as America’s leading branded vitamin-C supplement and led its ultimate sale to strategic acquirer Pfizer. Prior to Alacer, he held various general management and marketing roles at Zila Nutraceuticals, Bristol-Myers Squibb, Kellogg Company, and Johnson & Johnson.

Mr. Fugate holds an MBA from Columbia University and a BS in Business Administration from Juniata College. He currently serves on the Board of Linden portfolio company MeriCal, a leading probiotic contract development and manufacturer, and he formerly served on the Executive Committee of the Council for Responsible Nutrition. He actively supports a range of charities addressing food insecurity and health science research.